Skip to content

Clinical trials

Phase 1/2 Blood Coagulation Disorders trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Blood Coagulation Disorders Phase: Phase 1/2 Country / region: United Kingdom Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20151
20181
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical3
Novartis Pharmaceuticals1
Vega Therapeutics, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Blood Coagulation Disorders5
Hematologic Diseases4
Hemorrhagic Disorders4
Hemostatic Disorders4
Blood Coagulation Disorders, Inherited3
Coagulation Protein Disorders3
Genetic Diseases, Inborn3
Hemophilia A3
Blood Platelet Disorders1
Bone Marrow Diseases1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.